SCHEMBL7657278

SCHEMBL7657278

CCCCC(NC(=O)c1ccccc1-c1ccccc1)C(=O)CNC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLPP Q16740 2/20 0.44
CHRNB2 P17787 2/20 0.44
CHRNB4 P30926 2/20 0.44
CHRNA3 P32297 2/20 0.44
CHRNA4 P43681 2/20 0.44
CAPN1 P07384 4/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NPFFR1 Q9GZQ6 1/20 0.41
NPFFR2 Q9Y5X5 1/20 0.41
LTB4R2 Q9NPC1 1/20 0.41
TACR3 P29371 2/20 0.41
DRD3 P35462 1/20 0.40
TACR2 P21452 1/20 0.40
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PPARG P37231 1/20 0.39
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7659419 0.90 NAAA (0.44) CLPPCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7428183 0.84 LTB4R2 (0.44) CLPPCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7698402 0.83 CHRNB2 (0.52) CLPPCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7659831 0.83 KDM4E (0.48) MEN1KMT2ALMNAHTTNPSR1
SCHEMBL7428250 0.82 KCNA5 (0.44) CLPPCAPN1MEN1KMT2A
SCHEMBL7696167 0.81 CAPN1 (0.57) CAPN1FNTAFNTB
SCHEMBL7697277 0.76 CAPN1 (0.47) CAPN1KMT2A
SCHEMBL7696690 0.75 CAPN1 (0.54) CAPN1TACR3
SCHEMBL18086870 0.74 CHRNB2 (0.52) CHRNB2CHRNB4CHRNA3CHRNA4MEN1
SCHEMBL7666903 0.73 KDM4E (0.47) MEN1KMT2ALMNAHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed